Recurrent cardiocirculatory arrest after kidney transplantation related to intravenous methylprednisolone bolus therapy.
Standard
Recurrent cardiocirculatory arrest after kidney transplantation related to intravenous methylprednisolone bolus therapy. / Schult, M; Löhmann, D; Knitsch, W; Kuse, E R; Nashan, Björn.
in: TRANSPLANTATION, Jahrgang 67, Nr. 11, 11, 1999, S. 1497-1498.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Recurrent cardiocirculatory arrest after kidney transplantation related to intravenous methylprednisolone bolus therapy.
AU - Schult, M
AU - Löhmann, D
AU - Knitsch, W
AU - Kuse, E R
AU - Nashan, Björn
PY - 1999
Y1 - 1999
N2 - BACKGROUND: Intravenous bolus therapy with steroids is often used in standard immunosuppression initially after organ transplantation and to treat acute graft rejection. Although this regimen in generally is safe, severe adverse effects can occur. METHODS: This letter gives a picture of the eventful clinical course of a patient with preexisting heard problems after renal transplantation. RESULTS: This case report proves lethal cardiopulmonary complications closely related to the recurrent intravenous administration of methylprednisolone in a risk patient. CONCLUSIONS: Severe side effects after the application of high-dose steroids are possible. If risk patients are identified, steroid bolus therapy should be avoided or, if not possible, should only be done under close monitoring.
AB - BACKGROUND: Intravenous bolus therapy with steroids is often used in standard immunosuppression initially after organ transplantation and to treat acute graft rejection. Although this regimen in generally is safe, severe adverse effects can occur. METHODS: This letter gives a picture of the eventful clinical course of a patient with preexisting heard problems after renal transplantation. RESULTS: This case report proves lethal cardiopulmonary complications closely related to the recurrent intravenous administration of methylprednisolone in a risk patient. CONCLUSIONS: Severe side effects after the application of high-dose steroids are possible. If risk patients are identified, steroid bolus therapy should be avoided or, if not possible, should only be done under close monitoring.
M3 - SCORING: Zeitschriftenaufsatz
VL - 67
SP - 1497
EP - 1498
JO - TRANSPLANTATION
JF - TRANSPLANTATION
SN - 0041-1337
IS - 11
M1 - 11
ER -
